Welichem Biotech (Canada)

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors

Paul C. McDonald, Stephen Chia, Philippe L. Bédard et al. · American Journal of Clinical Oncology · 2020 · 235 citations · Full text

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial

Robert Bissonnette, Yves Poulin, Yabo Zhou et al. · British Journal of Dermatology · 2011 · 92 citations

Fetal MEG Redistribution by Projection Operators

Jan Vrba, Stephen E. Robinson, J. Adam McCubbin et al. · IEEE Transactions on Biomedical Engineering · 2004 · 84 citations

Redistribution Correction, Neuroimaging Modality, Dipole Forward Solution +15

Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial

Robert Bissonnette, Chantal Bolduc, Catherine Maari et al. · Journal of the European Academy of Dermatology and Venereology · 2011 · 71 citations

Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: Synthesis, structure–activity relationships, and cytotoxic activity on selected human cancer cell lines

Bin Li, Michael P. A. Lyle, Genhui Chen et al. · Bioorganic & Medicinal Chemistry · 2007 · 64 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +8